Yan Fanghong, Zhang Yuanyuan, Pan Yayan, Li Sijun, Yang Mengqi, Wang Yutan, Yanru Chen, Su Wenli, Ma Yuxia, Han Lin
Evidence-Based Nursing Center, School of Nursing, Lanzhou University, Lanzhou, China.
TheFirst School of Clinical Medicine, Lanzhou University, Lanzhou, China.
J Res Med Sci. 2023 Mar 16;28:17. doi: 10.4103/jrms.jrms_781_21. eCollection 2023.
There is a paucity of systematic reviews on the associated factors of mortality among ST-elevation myocardial infarction (STEMI) patients after percutaneous coronary intervention (PCI). This meta-analysis was designed to synthesize available evidence on the prevalence and associated factors of mortality after PCI for adult patients with STEMI.
Databases including the Cochrane Library, PubMed, Web of Science, Embase, Ovid, Scopus, ProQuest, MEDLINE, and CINAHL Complete were searched systematically to identify relevant articles published from January 2008 to March 2020 on factors affecting mortality after PCI in STEMI patients. Meta-analysis was conducted using Stata 12.0 software package.
Our search yielded 91 cohort studies involving a total of 199, 339 participants. The pooled mortality rate for STEMI patients after PCI was 10%. After controlling for grouping criteria or follow-up time, the following 17 risk factors were significantly associated with mortality for STEMI patients after PCI: advanced age (odds ratio [OR] = 3.89), female (OR = 2.01), out-of-hospital cardiac arrest (OR = 5.55), cardiogenic shock (OR = 4.83), renal dysfunction (OR = 3.50), admission anemia (OR = 3.28), hyperuricemia (OR = 2.71), elevated blood glucose level (OR = 2.00), diabetes mellitus (OR = 1.8), chronic total occlusion (OR = 2.56), Q wave (OR = 2.18), without prodromal angina (OR = 2.12), delay in door-to-balloon time (OR = 1.72), delay in symptom onset-to-balloon time (OR = 1.43), anterior infarction (OR = 1.66), ST-segment resolution (OR = 1.40), and delay in symptom onset-to-door time (OR = 1.29).
The pooled prevalence of mortality after PCI for STEMI patients was 10%, and 17 risk factors were significantly associated with mortality for STEMI patients after PCI.
关于ST段抬高型心肌梗死(STEMI)患者经皮冠状动脉介入治疗(PCI)后死亡相关因素的系统评价较少。本荟萃分析旨在综合现有证据,探讨成年STEMI患者PCI术后死亡的发生率及相关因素。
系统检索Cochrane图书馆、PubMed、Web of Science、Embase、Ovid、Scopus、ProQuest、MEDLINE和CINAHL Complete等数据库,以识别2008年1月至2020年3月发表的有关影响STEMI患者PCI术后死亡因素的相关文章。使用Stata 12.0软件包进行荟萃分析。
我们的检索共获得91项队列研究,涉及199339名参与者。STEMI患者PCI术后的合并死亡率为10%。在控制分组标准或随访时间后,以下17个危险因素与STEMI患者PCI术后死亡显著相关:高龄(比值比[OR]=3.89)、女性(OR=2.01)、院外心脏骤停(OR=5.55)、心源性休克(OR=4.83)、肾功能不全(OR=3.50)、入院时贫血(OR=3.28)、高尿酸血症(OR=2.71)、血糖水平升高(OR=2.00)、糖尿病(OR=1.8)、慢性完全闭塞(OR=2.56)、Q波(OR=2.18)、无前驱性心绞痛(OR=2.12)、门球时间延迟(OR=1.72)、症状发作至球囊时间延迟(OR=1.43)、前壁梗死(OR=1.66)、ST段回落(OR=1.40)以及症状发作至门时间延迟(OR=1.29)。
STEMI患者PCI术后的合并死亡率为10%,17个危险因素与STEMI患者PCI术后死亡显著相关。